• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ezecor
    / Unipharm

    Active Ingredient
    Ezetimibe 10 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 X 10 mg

    not in the basket chart 50193


    Adults and adolescents (10 to 17 years of age): The dosage is one tablet (10mg), taken orally, once a day. Ezetimibe can be taken at any hour of the day with or without food with a small amount of water. The tablet can be crushed for immediate use. Cholesterol-lowering diet should be initiated before treatment initiation with this drug and continued during administration of this drug.


    Primary hypercholesterolemia: Ezetimibe administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia.
    Homozygous familial hypercholesterolemia (HoFH): Ezetimibe administered with a statin are indicated for use in patients with HoFH.
    Patients may also receive adjunctive treatments (e.g. LDL apheresis).
    Homozygous sitosterolemia (Phytosterolemia): Ezetimibe are indicated for use in patients with homozygous familial sitosterolemia.


    Hypersensitivity to active substance or to its excipients.
    Contomitant use with statin, in patients with hepatic impairment.
    Contomitant use with statin, during pregnancy and lactation.

    Important notes

    Lactose: no content of lactose.

    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel